Top compounds associated with response to CCP110


Feature Type Standardized
Nominal ANOVA
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 8e-07
mRNA SN-38 CTRPv2 pan-cancer AAC 0.18 9e-07
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 1e-06
mRNA Parthenolide CTRPv2 pan-cancer AAC 0.19 1e-06
mRNA BX-912 GDSC1000 pan-cancer AAC 0.16 1e-06
mRNA Topotecan CTRPv2 pan-cancer AAC 0.16 1e-06
mRNA piperlongumine CTRPv2 pan-cancer AAC 0.16 2e-06
mRNA Cetuximab GDSC1000 pan-cancer AAC -0.17 2e-06
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.17 2e-06
mRNA KPT185 CTRPv2 pan-cancer AAC 0.18 3e-06
Download CSV